Established in Bangladesh in 1999, Incepta Pharmaceuticals manufactures medicines and vaccines from its large Savar and Dhamrai operations, with a particular focus on advanced dosage forms and biologic products. Its roughly 100,000-square-metre Zirabo plant and research operation of about 170 people support a portfolio exceeding 1,100 products, while the company exports through partners in 102 countries. Incepta was also the first Bangladeshi company to acquire technology for producing human vaccines.
Current Good Manufacturing Practice (cGMP)
compliance_program
PICS and WHO Guidelines-Based Quality Management System
compliance_program
GMP Compliance
compliance_program